Neonatal Abstinence Syndrome
Substance abuse, including abuse of opioids, have reached epidemic proportions in the United States. The rate of opioid abuse during pregnancy has also seen an approximate three-fold increase in the last few years. Mississippi has seen a sharp increase in Neonatal Abstinence Syndrome (NAS) patients over the last several years with an almost 10-fold increase in identified cases from 2010-2016. A lack of a formal monitoring system for NAS patients and variable practices in tracking NAS likely underestimates the actual number of NAS patients identified through ICD codes.
|PBP 1: Develop and implement a standardized process for the identification, evaluation, treatment, and discharge of infants with NAS.|
|PBP 2: Develop and implement a standardized process for measuring and reporting rates of neonatal abstinence syndrome and drug exposure.|
|PBP 3: Provide care for infants and families in sites that promote parental engagement in care and avoid separation of mothers and infants.|
|PBP 4: Engage mothers and family members in providing non-pharmacologic interventions as “first-line” therapy for all substance-exposed infants.|
|PBP 5: Develop a standardized process to ensure safe discharge into the community.|
|PBP 6: Provide interdisciplinary universal education and training to all caregivers who may encounter substance-exposed infants and families|